Tocilizumab in Cardiac Transplantation

Clinical trial NCT03644667 · COMPLETED

Trial details

NCT number: NCT03644667
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Transplant

Start date: 2018-12-20
Primary completion: 2025-03-25
Enrollment: 385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.